Advanced Search


Study ID Status Title Patient Level Data
112925 Completed Special Drug Use Investigation for AMERGE Tablet (Long-term)
112929 Completed A Phase 2a Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK1265744 Monotherapy Versus Placebo in HIV-1 Infected Adults (ITZ112929)
112930 Completed An open-label, randomized, adaptive design, two-period crossover study in cancer patients to evaluate the bioequivalence of alternative formulations of lapatinib compared to the commercial tablet
112931 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals’ Hib-MenCY-TT vaccine 792014 compared to Merck & Co, Inc. Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) vaccine in healthy infants and toddlers
112933 Completed Booster vaccination with pneumococcal vaccine GSK1024850A or Prevenar™ co-administered with Hiberix™ in children primed with the same vaccines Study Listed on
112934 Completed A Phase I, open label, randomized, three period, one-way, two cohort, adaptive crossover study to evaluate the effect of darunavir/ritonavir plus etravirine and lopinavir/ritonavir plus etravirine on GSK1349572 pharmacokinetics in healthy adult subjects (ING112934)
112937 Completed Retrospektive Studie zu Patientinnen, die pränatal, perinatal oder postnatal prophylaktisch oder therapeutisch mit Fondaparinux behandelt wurden
112940 Completed A longitudinal 2-year bone marrow study of eltrombopag olamine (SB-497115-GR) in previously treated adults, with chronic immune (idiopathic) thrombocytopenic purpura (ITP)
112941 Completed The official study title exceeds the 300 character limit for this field. See Detailed Study Description Section for official study title.
112949 Completed Long-term extension study of the efficacy of the 580299 vaccine in the prevention of HPV-16 and/or HPV-18 associated cervical intraepithelial neoplasia (CIN) in Japanese women vaccinated in the primary vaccination study NCT00316693 Study Listed on
112950_1 Completed Assessment of coincident Nausea and Vomiting (N&V) with upper gastrointestinal bleeding (UGIB) in Cancer Patients Treated with Chemotherapy: Results from Pooled Clinical Trials Data
112952_1 Completed Demographic and clinical differences in patients receiving PI and NNRTI regimens, & Factors associated with hepatic outcomes
112956 Terminated Identification and characterisation of bacteria causing chronic cough among children in the United Kingdom
112957 Completed Phase III, partially double-blind study to evaluate consistency and immunogenicity of 3 lots of GSK Biologicals' Hib conjugate vaccine 208108 versus ActHIB and Pentacel at 2, 4, 6 and 15-18 months of age in healthy infants
112958 Completed A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects with post-stroke upper limb spasticity
112961 Completed A pilot study to assess the antiviral activity of GSK1349572 containing regimen in antiretroviral therapy (ART)-experienced, HIV-1-infected adult subjects with raltegravir resistance
112963 Completed Immunogenicity, Reactogenicity and Safety of GSK Biologicals' Quadrivalent Influenza Vaccine FLU Q-QIV (GSK2282512A) When Administered Intramuscularly to Adults 18 Years of Age and Older Study Listed on
112967 Completed A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from peripheral nerve injury Study Listed on
112988 Terminated A randomized, double-blind, placebo-controlled, single ascending dose study exploring the preliminary safety, tolerability and pharmacokinetics of GSK1223249 administered by intravenous (IV) infusion to patients with relapsing forms of multiple sclerosis, not on disease modifying therapy.
112989 Completed Validation of a New Shortness of Breath with Daily Activities Questionnaire in patients with Chronic Obstructive Pulmonary Disease Study Listed on
112993 Completed A study to evaluate safety and immunogenicity of a booster dose of two formulations of GSK Biologicals’ pneumococcal candidate vaccine in healthy young adults Study Listed on
112994 Completed An epidemiological study to evaluate the incidence, clinical characteristics and economic burden of dengue in Brazilian children
112997 Completed A multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to determine the effect of mepolizumab on exacerbation rates in subjects with severe uncontrolled refractory asthma Study Listed on
112999 Completed Immunogenicity & safety study of GSK Biologicals’ thimerosal-free trivalent influenza vaccine (TIV) versus a licensed comparator in children Study Listed on
113006 Completed A Study to Evaluate the Efficacy and Safety of Losmapimod (GW856553) Tablets Administered Twice Daily compared with Placebo for 24 Weeks in Adult Subjects with Chronic Obstructive Pulmonary Disease (COPD). Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.